NAT1-IN-1
NAT1-IN-1 (compound 350) is a potent N-acetyltransferase 1 (NAT1) -targeted inhibitor, with an IC50 of 44 nM. NAT1-IN-1 can be used for the research of hypermetabolic diseases such as amyotrophic lateral sclerosis, cancer cachexia, and sepsis[1].
Product Specifications
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/nat1-in-1.html
Purity
99.77
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=S(NC1=C(NC2=CC=C(CC(O)=O)C=C2)C(C3=CC=CC=C3C1=O)=O)(C4=CC=CC=C4)=O
Molecular Formula
C24H18N2O6S
Molecular Weight
462.47
References & Citations
[1]Chandra Choudhury, et al. Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human Macrophage Inflammatory protein-3 (CCL23), T7 Tag
Recombinant Human Macrophage Inflammatory protein-3 (CCL23), T7 Tag
Recombinant Human Macrophage Inflammatory protein-3 (CCL23), T7 Tag
Recombinant Human Macrophage Inflammatory protein-3 (CCL23), T7 Tag
